0001567619-22-011518.txt : 20220523
0001567619-22-011518.hdr.sgml : 20220523
20220523163119
ACCESSION NUMBER: 0001567619-22-011518
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220520
FILED AS OF DATE: 20220523
DATE AS OF CHANGE: 20220523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhen Marianne
CENTRAL INDEX KEY: 0001750085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 22952146
MAIL ADDRESS:
STREET 1: C/O INNOVIVA, INC.
STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 1350 OLD BAYSHORE HIGHWAY
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
doc1.xml
FORM 4
X0306
4
2022-05-20
0
0001080014
Innoviva, Inc.
INVA
0001750085
Zhen Marianne
1350 OLD BAYSHORE HIGHWAY, SUITE 400
BURLINGAME
CA
94040
0
1
0
0
Chief Accounting Officer
Common Stock
2022-05-13
4
A
0
1834
0
A
40706
D
Common Stock
2022-05-20
4
F
0
828
16.29
D
39878
D
Includes 1,834 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 13, 2022.
The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
/s/ Marianne Zhen
2022-05-23